Prasad Abhiram, Stone Gregg W, Aymong Eve, Zimetbaum Peter J, McLaughlin Michael, Mehran Roxana, Garcia Eulogio, Tcheng James E, Cox David A, Grines Cindy L, Gersh Bernard J
Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn., USA.
Am Heart J. 2004 Apr;147(4):669-75. doi: 10.1016/j.ahj.2003.11.010.
Age is a strong independent predictor of outcomes after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Whether lower rates of reperfusion success contribute to the poor prognosis in elderly patients is unknown.
A formal ST-segment analysis substudy was performed in 695 patients undergoing primary PCI for AMI in the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Reperfusion success (determined by the magnitude of ST-segment elevation resolution [STR] after PCI) was evaluated in 4 age groups: <50 years (n = 163), >or=50 to <60 years (n = 187), >or=60 to <70 years (n = 194), and >or=70 years (n = 151).
There were no differences in the age groups for angiographic procedural success (>91% in all, P =.6), postprocedural Thrombolysis in Myocardial Infarction grade 3 flow (>94%, P =.8), and the proportions of patients with complete, partial, or absent STR (P >.8). However, rates of 30-day mortality (0.6%, 1.1%, 3.6%, 6.0%, respectively) and major adverse cardiac events (MACE; 2.5%, 4.8%, 6.2% 9.3%, respectively) increased with age. Rates of mortality and MACE were also inversely related to the magnitude of STR. Absent STR (hazard ratio, 3.00; 95% CI, 1.37-6.58; P =.006) and age (hazard ratio, 1.34; 95% CI, 1.01-1.77; P =.04) were independent predictors of 30-day MACE by using multivariable modeling.
Lack of effective myocardial reperfusion is not a contributory mechanism responsible for the high morbidity and mortality rates observed in elderly patients. Nevertheless, advanced age and absent STR are both independent predictors of adverse outcomes after primary PCI, emphasizing the importance of successful reperfusion in the elderly population.
年龄是急性心肌梗死(AMI)患者接受直接经皮冠状动脉介入治疗(PCI)后预后的一个强有力的独立预测因素。再灌注成功率较低是否导致老年患者预后不良尚不清楚。
在“抑制晚期血管成形术并发症的阿昔单抗和器械对照研究(CADILLAC)”试验中,对695例行AMI直接PCI的患者进行了一项正式的ST段分析子研究。在4个年龄组中评估再灌注成功率(根据PCI后ST段抬高分辨率[STR]的幅度确定):<50岁(n = 163)、≥50至<60岁(n = 187)、≥60至<70岁(n = 194)和≥70岁(n = 151)。
各年龄组在血管造影手术成功率(均>91%,P = 0.6)、术后心肌梗死溶栓3级血流(>94%,P = 0.8)以及完全、部分或无STR患者的比例方面无差异(P > 0.8)。然而,30天死亡率(分别为0.6%、1.1%、3.6%、6.0%)和主要不良心脏事件(MACE;分别为2.5%、4.8%、6.2%、9.3%)随年龄增加。死亡率和MACE发生率也与STR幅度呈负相关。无STR(风险比,3.00;95%CI,1.37 - 6.58;P = 0.006)和年龄(风险比,1.34;95%CI,1.01 - 1.77;P = 0.04)是通过多变量模型预测30天MACE的独立因素。
缺乏有效的心肌再灌注不是导致老年患者高发病率和死亡率的原因。然而,高龄和无STR都是直接PCI后不良结局的独立预测因素,强调了老年人群成功再灌注的重要性。